Antidiabetic actions of aqueous bark extract of Swertia chirayita on insulin secretion, cellular glucose uptake and protein glycation

HAJ Thomson, Opeolu Ojo, Peter Flatt, YHA Abdel-Wahab

Research output: Contribution to journalArticle

Abstract

Objective: There is renewed scientific interest in the potential of plant-derived agents for the treatment ofdiabetes mellitus. This study investigated the antidiabetic actions of Swertia chirayita, a plant used traditionally inthe management of diabetes. Materials and Methods: Insulin secretion from BRIN-DB11 cells was assessedin the absence or presence of plant extract and modulators of beta cell function. Glucose uptake was assessedusing 3T3-L1 cells while effects of the plant extract on protein glycation was assessed using model peptide.Insulin was measured by radioimmunoassay and intracellular calcium by FlexStation®. Results: S. chirayitasignificantly stimulated concentration-dependent insulin secretion from BRIN-BD11 cells. Its insulinotropiceffects were abolished in the absence of extracellular Ca2 + or by diazoxide and were significantly decreasedby verapamil and in beta cell depolarization with KCl. S. chirayita extracts evoked a 28-59% increase in basaland insulin-stimulated glucose uptake by 3T3-L1 cells. Protein glycation was significantly inhibited by S. chirayitain a dose-dependent manner. Conclusion: This study reveals that the antidiabetic actions of S. chirayitaaqueous bark extracts involves the stimulation of insulin secretion and enhancement of insulin action. Inhibitionof protein glycation may also help counter diabetic complications. These actions of S. chirayita may providenew opportunities for the treatment of diabetes.
LanguageEnglish
Pages268-272
JournalJournal of Experimental and Integrative Medicine
Volume4
Issue number3
DOIs
Publication statusPublished - 7 Dec 2014

Fingerprint

Swertia
Hypoglycemic Agents
Insulin
Glucose
3T3-L1 Cells
Proteins
Plant Extracts
Diazoxide
Diabetes Complications
Verapamil
Radioimmunoassay
Calcium
Peptides

Keywords

  • Insulin action
  • protein glycation
  • Swertia chirayita
  • Type 2 diabetes

Cite this

@article{bbeabf5c215f4160920a6da38e61d9e5,
title = "Antidiabetic actions of aqueous bark extract of Swertia chirayita on insulin secretion, cellular glucose uptake and protein glycation",
abstract = "Objective: There is renewed scientific interest in the potential of plant-derived agents for the treatment ofdiabetes mellitus. This study investigated the antidiabetic actions of Swertia chirayita, a plant used traditionally inthe management of diabetes. Materials and Methods: Insulin secretion from BRIN-DB11 cells was assessedin the absence or presence of plant extract and modulators of beta cell function. Glucose uptake was assessedusing 3T3-L1 cells while effects of the plant extract on protein glycation was assessed using model peptide.Insulin was measured by radioimmunoassay and intracellular calcium by FlexStation{\circledR}. Results: S. chirayitasignificantly stimulated concentration-dependent insulin secretion from BRIN-BD11 cells. Its insulinotropiceffects were abolished in the absence of extracellular Ca2 + or by diazoxide and were significantly decreasedby verapamil and in beta cell depolarization with KCl. S. chirayita extracts evoked a 28-59{\%} increase in basaland insulin-stimulated glucose uptake by 3T3-L1 cells. Protein glycation was significantly inhibited by S. chirayitain a dose-dependent manner. Conclusion: This study reveals that the antidiabetic actions of S. chirayitaaqueous bark extracts involves the stimulation of insulin secretion and enhancement of insulin action. Inhibitionof protein glycation may also help counter diabetic complications. These actions of S. chirayita may providenew opportunities for the treatment of diabetes.",
keywords = "Insulin action, protein glycation, Swertia chirayita, Type 2 diabetes",
author = "HAJ Thomson and Opeolu Ojo and Peter Flatt and YHA Abdel-Wahab",
year = "2014",
month = "12",
day = "7",
doi = "10.5455/jeim.160814",
language = "English",
volume = "4",
pages = "268--272",
journal = "Journal of Experimental and Integrative Medicine",
issn = "1309-4572",
number = "3",

}

TY - JOUR

T1 - Antidiabetic actions of aqueous bark extract of Swertia chirayita on insulin secretion, cellular glucose uptake and protein glycation

AU - Thomson, HAJ

AU - Ojo, Opeolu

AU - Flatt, Peter

AU - Abdel-Wahab, YHA

PY - 2014/12/7

Y1 - 2014/12/7

N2 - Objective: There is renewed scientific interest in the potential of plant-derived agents for the treatment ofdiabetes mellitus. This study investigated the antidiabetic actions of Swertia chirayita, a plant used traditionally inthe management of diabetes. Materials and Methods: Insulin secretion from BRIN-DB11 cells was assessedin the absence or presence of plant extract and modulators of beta cell function. Glucose uptake was assessedusing 3T3-L1 cells while effects of the plant extract on protein glycation was assessed using model peptide.Insulin was measured by radioimmunoassay and intracellular calcium by FlexStation®. Results: S. chirayitasignificantly stimulated concentration-dependent insulin secretion from BRIN-BD11 cells. Its insulinotropiceffects were abolished in the absence of extracellular Ca2 + or by diazoxide and were significantly decreasedby verapamil and in beta cell depolarization with KCl. S. chirayita extracts evoked a 28-59% increase in basaland insulin-stimulated glucose uptake by 3T3-L1 cells. Protein glycation was significantly inhibited by S. chirayitain a dose-dependent manner. Conclusion: This study reveals that the antidiabetic actions of S. chirayitaaqueous bark extracts involves the stimulation of insulin secretion and enhancement of insulin action. Inhibitionof protein glycation may also help counter diabetic complications. These actions of S. chirayita may providenew opportunities for the treatment of diabetes.

AB - Objective: There is renewed scientific interest in the potential of plant-derived agents for the treatment ofdiabetes mellitus. This study investigated the antidiabetic actions of Swertia chirayita, a plant used traditionally inthe management of diabetes. Materials and Methods: Insulin secretion from BRIN-DB11 cells was assessedin the absence or presence of plant extract and modulators of beta cell function. Glucose uptake was assessedusing 3T3-L1 cells while effects of the plant extract on protein glycation was assessed using model peptide.Insulin was measured by radioimmunoassay and intracellular calcium by FlexStation®. Results: S. chirayitasignificantly stimulated concentration-dependent insulin secretion from BRIN-BD11 cells. Its insulinotropiceffects were abolished in the absence of extracellular Ca2 + or by diazoxide and were significantly decreasedby verapamil and in beta cell depolarization with KCl. S. chirayita extracts evoked a 28-59% increase in basaland insulin-stimulated glucose uptake by 3T3-L1 cells. Protein glycation was significantly inhibited by S. chirayitain a dose-dependent manner. Conclusion: This study reveals that the antidiabetic actions of S. chirayitaaqueous bark extracts involves the stimulation of insulin secretion and enhancement of insulin action. Inhibitionof protein glycation may also help counter diabetic complications. These actions of S. chirayita may providenew opportunities for the treatment of diabetes.

KW - Insulin action

KW - protein glycation

KW - Swertia chirayita

KW - Type 2 diabetes

U2 - 10.5455/jeim.160814

DO - 10.5455/jeim.160814

M3 - Article

VL - 4

SP - 268

EP - 272

JO - Journal of Experimental and Integrative Medicine

T2 - Journal of Experimental and Integrative Medicine

JF - Journal of Experimental and Integrative Medicine

SN - 1309-4572

IS - 3

ER -